Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis.
Journal: The New England journal of medicine
Published: October 27, 2021
Management of AL amyloidosis in 2021.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: September 13, 2021
Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis.
Journal: Blood
Published: September 11, 2020
One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: July 26, 2019
Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: April 25, 2017
A human monoclonal IgG that binds aβ assemblies and diverse amyloids exhibits anti-amyloid activities in vitro and in vivo.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: April 24, 2015
Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling.
Journal: BMC cancer
Published: October 30, 2012
Development and evaluation of agents for targeting visceral amyloid.
Journal: Tijdschrift voor nu[c]leaire geneeskunde
Published: December 01, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026